Overview

Biosignatures of Latuda for Bipolar Depression

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The study proposes to conduct a pilot study of biological predictors of lurasidone response in bipolar depression.
Phase:
N/A
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
Sunovion
Treatments:
Lurasidone Hydrochloride